TNF and myeloid sarcoma: The administration of Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium bifidum, and Lactobacillus fermentum to MS patients resulted in a decrease in proinflammatory cytokines, including IL-8 and TNF-α [201], and an improvement in disability, as measured by the expanded disability status scale (EDSS) [200].